The intersection of microglial and macrophage biology in glioblastoma (GBM) and Alzheimer’s disease (AD) illuminates potential common and contradictory therapeutic avenues, particularly those associated with NF-κB signaling pathways, although these avenues are well-trodden, with an extensive research history. The gene discussed is NFKB1; the disease is Alzheimer disease.